Gardasil vaccine for cervical cancer
Gardasil is the new cervical vaccine developed by Sanofi Pasteur and Merck and found to be effective in its phase III trial, the vaccine is given in three doses over 6 months which has shown 100% successful. The company is // to apply for a license this year. The vaccine protects against Human Papilloma virus infection and also genital warts, which infects both men and women. The Gardasil vacci...'Gardasil'- Cervical Cancer Vaccine Now Approved
Health officials have stated that Gardasil, which is a vaccine by Merck, for the prevention of cervical cancer, has now been approved for usage.// The drug Gardasil, which is reported to offer 100% protection against two hpv's that are associated with the onset of cervical cancer, making it a very practical option for young girls and women. Unfortunately reports have indi...Gardasil, a cervical cancer vaccine, hits the market
This is indeed an important milestone in the development of strategies to combat cervical abnormalities; the worlds first ever vaccine for cervical cancer, named Gardasil, has// made it to the market. A feather in the cap of Professor Frazer, a scientist in Queens land and the brain behind this vaccine, who has relentlessly worked on this working on it since 1990, is all set to admin...Gardasil Hailed as one of the Biggest Research Successes
A national screening program for cervical cancer has been called for by the Well Woman Centre.// This call was made following the announcement that a vaccine against cervical cancer is expected to be available in Ireland in four weeks time. Doctors have hailed the development of the vaccine, Gardasil, as one of the biggest research successes of recent times. Det...Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
The US Centers for Disease Control and Prevention (CDC) has decided to include Gardasil , Merck & Co.Inc's new cervical cancer vaccine // in its Vaccines for Children program. The program is government subsidized and covers uninsured or poor schoolchildren upto age 18 . The vaccine which was approved in June , will be given to young girls before they become sexually active....New England Journal of Medicine Publishes New Data on Gardasil, Merck's Cervical Cancer Vaccine
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-May 10, 2007--Today, theNew England Journal of Medicine is publishing results from twoPhase III studies of Merck's cervical cancer vaccine, Gardasil(Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18)Recombinant Vaccine). In the first study, Gardasil provided 100percent protection against cervical, vaginal and vulvar diseasescaused by the four H...Gardasil Demonstrates Up to 100% Efficacy
- In the Prevention of Cervical Cancer and Other HumanPapillomavirus Related Diseases After an Additional Year of FollowUp in Large Phase III Clinical Studies Which Included More Than17,000 Women New England Journal of Medicine publishes the most comprehensiveand robust clinical data for any Human Papillomavirus vaccine LYON, France, 10th May2007 – New clinical st...